Kawakami Mark

Kawakami Mark is listed in filings as Chief Financial Officer at Arcadia Biosciences, Inc.. This profile follows SEC Form 4 activity through May 12, 2025, including purchase activity. Recent filings connect the profile to Arcadia Biosciences, Inc. (RKDA). The current snapshot covers public activity from Aug 20, 2024 to May 12, 2025. Reported amounts are shown as $48.5K to $54.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.